Buy, Sell Or Hold: Tata Motors, Akums Drugs, IOC, BEL — Ask Profit

Should you buy shares of Akums Drugs and Pharmaceuticals Ltd. at the current price? Are Bharat Electronics Ltd. and Swan Energy Ltd. good choices from a long-term perspective? Should you keep holding Coforge Ltd.? Is it the right time to exit Som Distilleries & Breweries Ltd. and
Indian Oil Corp. to book profit?

Sunny Agarwal, head of fundamental equity research at SBICap Securities Ltd.; and Kush Bohra, founder of Kushbohra.com; answered these investor queries and more on NDTV Profit's Ask Profit show.

Agarwal: Hold.

• It is a mix of diversified business, and the recent trigger has been the acquisition of the Reliance Naval defence business.

• It is a high-risk, high-return story.

• I would recommend to stay invested in the company.

• It can give a return of a multibagger in the next two–three years.

Agarwal: Hold.

• I think stay remain invested, as of late, we are seeing stock price correction.

• We expect the December and March quarter to be much better than the September quarter.

Agarwal: Hold.

• We are bullish on the regional hospital business.

• You can add more share on dips, as far as Rainbow Childrens is considered.

Bohra: Hold.

• When it comes to the mid-cap space, Coforge is something that we are really bullish on.

• The stock could continue to do well up until Rs 9,000. It is just starting to reach the overrated territories in the technical front.

• Technically, we think Rs 9,000 levels and more is up for Coforge.

Agarwal: Exit and Switch.

• I will suggest that you switch from Som Distilleries to other stocks like Radico Khaitan Ltd. or Allied Blenders and Distilleries Ltd.

Agarwal: Hold.

• If you want to accumulate BEL, then I would suggest that any number below Rs 280 will add value to the portfolio.

Agarwal: Add.

• I feel the alpha from now on will be on Engineers India Ltd.

• The fair value of EIL is close to Rs 270–280.

• The company is backed by solid fundamentals and capex. It can deliver a better return in next two–three years.

Bohra: Hold.

• The stock has not been that spectacular, but rather encouraging so far.

• For a six-month perspective, you will be looking at Rs 61–67 levels in the upside.

Agarwal: Hold.

• The stock post-correction looks favourable.

• One needs to have a longer horizon.

• The fair value of the business is close to Rs 2,000, with an investment horizon of 12-18 months.

Agarwal: Buy.

• We have seen strong numbers at the contract-development-and-manufacturing-organisation front.

• Post this correction, one can add the stock at the current level.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.